PIMA549633

Albendazole Monoclonal Antibody (3H2), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA549633-Each-of-1 In Stock ₹ 33,553.00

PIMA549633 - Each of 1

₹ 33,553.00

In Stock

Quantity

1

Base Price: ₹ 33,553.00

GST (18%): ₹ 6,039.54

Total Price: ₹ 39,592.54

Antigen

Albendazole

Classification

Monoclonal

Concentration

6.6 mg/mL

Formulation

PBS with 0.09% sodium azide, pH 7.6

Immunogen

Conjugate of ABZ hapten and KLH

Quantity

200 μg

Primary or Secondary

Primary

Content And Storage

-20°, C, Avoid Freeze/Thaw Cycles

Isotype

IgG2a

Applications

ELISA, Immunohistochemistry, Lateral Flow, SDS-Page

Clone

3H2

Conjugate

Unconjugated

Host Species

Mouse

Purification Method

Protein G

Regulatory Status

RUO

Target Species

Mouse

Form

Liquid

Related Products

Img

Thermo Scientific

PIMA528960

--

Img

MilliporeSigma

MAB80124MI

--

Img

MilliporeSigma

MAB8002MI

--

Img

Thermo Scientific

PIMA526129

--

Img

Thermo Scientific

PIPA5113734

--

Img

MilliporeSigma

MABN48MI

--

Img

MilliporeSigma

04-158-5MI

--

Img

MilliporeSigma™

AP1168100UG

--

Description

  • Antibody tested in indirect ELISA Anthelmintics or anti-helminthics are a class of drugs that are effective against a range of intestinal parasitic worms (helminths)
  • Parasitic helminths must maintain an appropriate feeding site
  • Nematodes and trematodes must actively ingest and move food through their digestive tracts to maintain an appropriate energy state; these together with reproductive processes require a well defined and developed neuromuscular coordination
  • Anthelmintic treatment is a multi-targeting system designed to interfere with the integrity of parasite cells
  • The pharmacologic basis of the treatment for helminths involves the targeting of neuromuscular coordination, or protective mechanisms against host immunity, which lead to starvation, paralysis, and expulsion of the parasite
  • The benzimidazole class of drugs were introduced in 1961 and interfere with the parasite's ATP pathway on a cellular level.